NM_000152.5:c.547-4C>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.547-4C>G in gnomAD v2.1.1 is 0.7403 in the European non-Finnish population. Note that the minor allele frequency is even higher in the Ashkenazi Jewish (0.77927) and European Finnish (0.75914) populations. These allele frequencies are higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), meeting this criterion. There is a ClinVar entry for this variant (Variation ID: 92485, two star review status), with 6 submitters classifying the variant as benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145784/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.66 ( 33579 hom., cov: 32)
Exomes 𝑓: 0.71 ( 372392 hom. )

Consequence

GAA
NM_000152.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00004151
2

Clinical Significance

Benign reviewed by expert panel U:1B:15

Conservation

PhyloP100: -0.139

Publications

23 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.547-4C>G
splice_region intron
N/ANP_000143.2P10253
GAA
NM_001079803.3
c.547-4C>G
splice_region intron
N/ANP_001073271.1P10253
GAA
NM_001079804.3
c.547-4C>G
splice_region intron
N/ANP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.547-4C>G
splice_region intron
N/AENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.547-4C>G
splice_region intron
N/AENSP00000374665.3P10253
GAA
ENST00000933406.1
c.547-4C>G
splice_region intron
N/AENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.657
AC:
99789
AN:
151900
Hom.:
33566
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.559
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.540
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.667
GnomAD2 exomes
AF:
0.669
AC:
166767
AN:
249394
AF XY:
0.683
show subpopulations
Gnomad AFR exome
AF:
0.538
Gnomad AMR exome
AF:
0.475
Gnomad ASJ exome
AF:
0.780
Gnomad EAS exome
AF:
0.529
Gnomad FIN exome
AF:
0.759
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.720
GnomAD4 exome
AF:
0.712
AC:
1037625
AN:
1457634
Hom.:
372392
Cov.:
50
AF XY:
0.713
AC XY:
517028
AN XY:
725362
show subpopulations
African (AFR)
AF:
0.539
AC:
18025
AN:
33430
American (AMR)
AF:
0.489
AC:
21878
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20433
AN:
26122
East Asian (EAS)
AF:
0.560
AC:
22205
AN:
39682
South Asian (SAS)
AF:
0.670
AC:
57728
AN:
86214
European-Finnish (FIN)
AF:
0.763
AC:
39196
AN:
51352
Middle Eastern (MID)
AF:
0.798
AC:
4589
AN:
5750
European-Non Finnish (NFE)
AF:
0.730
AC:
810788
AN:
1110078
Other (OTH)
AF:
0.710
AC:
42783
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.426
Heterozygous variant carriers
0
17196
34391
51587
68782
85978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19864
39728
59592
79456
99320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.657
AC:
99831
AN:
152018
Hom.:
33579
Cov.:
32
AF XY:
0.654
AC XY:
48619
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.536
AC:
22194
AN:
41430
American (AMR)
AF:
0.558
AC:
8531
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.770
AC:
2672
AN:
3468
East Asian (EAS)
AF:
0.540
AC:
2792
AN:
5166
South Asian (SAS)
AF:
0.657
AC:
3168
AN:
4824
European-Finnish (FIN)
AF:
0.775
AC:
8196
AN:
10572
Middle Eastern (MID)
AF:
0.847
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
0.736
AC:
50030
AN:
67958
Other (OTH)
AF:
0.667
AC:
1407
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1718
3436
5154
6872
8590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.707
Hom.:
9153
Bravo
AF:
0.638
Asia WGS
AF:
0.580
AC:
2020
AN:
3478
EpiCase
AF:
0.741
EpiControl
AF:
0.741

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Glycogen storage disease, type II (6)
-
-
5
not specified (5)
-
1
3
not provided (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.6
DANN
Benign
0.53
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000042
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816256; hg19: chr17-78079544; COSMIC: COSV56408701; COSMIC: COSV56408701; API